Your browser doesn't support javascript.
loading
CBT-Intervention for panic disorder in primary care: 5 years follow-up of a cRCT during the Covid-19 pandemic.
Lukaschek, Karoline; Haas, Carolin; Wannemüller, André; Brettschneider, Christian; Dreischulte, Tobias; Margraf, Jürgen; Gensichen, Jochen.
Afiliação
  • Lukaschek K; Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Haas C; Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Wannemüller A; Graduate Program "POKAL-Predictors and Outcomes in Primary Care Depression Care" (DFG-GrK 2621), Munich, Germany.
  • Brettschneider C; Mental Health Research and Treatment Center, Ruhr-University Bochum, Bochum, Germany.
  • Dreischulte T; Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Margraf J; Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Gensichen J; Mental Health Research and Treatment Center, Ruhr-University Bochum, Bochum, Germany.
PLoS One ; 18(6): e0287718, 2023.
Article em En | MEDLINE | ID: mdl-37390059
ABSTRACT
A practice team-based exercise programme with elements of cognitive behavioural therapy (CBT) and case management for patients with panic disorder with or without agoraphobia in primary care showed significant positive effects. Here, we analyse the long-term effects (>5 years) of this intervention in the stressful context of the Covid-19 pandemic. All participants of the original PARADIES cluster randomized controlled trial (cRCT; 2012-2016) were invited to participate in a follow-up during the Covid-19 pandemic. Clinical outcomes were anxiety symptoms, number and severity of panic attacks, agoraphobic avoidance behaviour, Covid-specific anxiety symptom severity, depression, and patient assessment of chronic illness care. Data were analysed cross-sectionally for group differences (intervention, control) and longitudinally (T0 baseline, T1 6 months and TCorona >60 months). Of the original 419 participants, 100 participated in the 60 months follow-up (October 2020-May 2021). In the cross-sectional analysis, the anxiety symptom severity in the intervention group was lower than in the control group (p = .011, Cohen's d = .517). In the longitudinal analysis, both groups showed an increase of anxiety and depression symptoms compared to pre-pandemic level. The intervention may have had a lasting impact regarding anxiety severity despite the challenging context of the Covid-19 pandemic. However, we cannot say to what extend the intervention still played a role in participants' lives; other factors may also have helped with coping. The increase of anxiety and depression symptoms in both groups over time could be attributed to external circumstances.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Cognitivo-Comportamental / Transtorno de Pânico / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Cognitivo-Comportamental / Transtorno de Pânico / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha